Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:1290-1295

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pareti, F. I.
Right arrow Articles by Ruggeri, Z. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pareti, F. I.
Right arrow Articles by Ruggeri, Z. M.
Related Collections
Right arrow Valvular heart disease
Right arrow Ablation/ICD/surgery
Right arrow Other diagnostic testing
Right arrow CV surgery: valvular disease
Right arrow Platelets

(Circulation. 2000;102:1290.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis

F. I. Pareti, MD; A. Lattuada, BSc; C. Bressi, BSc; M. Zanobini, MD; A. Sala, MD; A. Steffan, MD; Z. M. Ruggeri, MD

From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Department of Internal Medicine (F.I.P., A.L., C.B.), IRCCS Maggiore Hospital, Milan; Chair of Cardiac Surgery (M.Z.), Fondazione Monzino, Milan; Division of Cardiac Surgery (A. Sala), Ospedale di Circolo, Fondazione Macchi, Varese; and the Departments of Blood Transfusion and Clinical Pathology (A. Steffan), IRCCS-CRO, Aviano, Italy; and the Departments of Molecular and Experimental Medicine and of Vascular Biology (Z.M.R.), The Scripps Research Institute, La Jolla, Calif.

Correspondence to F.I. Pareti, Department of Internal Medicine, University of Milan, Via Pace 9, 20122 Milan, Italy. E-mail Francesco.Pareti{at}unimi.it

Background—Excessive bleeding may complicate congenital cardiac defects. To explain the pathogenesis of this abnormality, we evaluated selected parameters of primary hemostasis in patients with aortic valve stenosis before and after corrective surgery.

Methods and Results—We examined shear-induced platelet aggregation with the filter aggregometer test and von Willebrand factor (vWF) structure by evaluating the multimeric distribution and extent of subunit proteolysis. The platelet count was reduced before corrective surgery, and shear-induced platelet aggregation was impaired. Moreover, vWF multimers of higher molecular mass were decreased, and proteolytic subunit fragments were increased. After correction of the cardiac defect, all of these parameters returned to normal.

Conclusions—Alterations of vWF and platelet function may contribute to the bleeding diathesis in patients with aortic valve stenosis. Improvement after corrective surgery suggests that the passage of blood through a stenosed aortic valve may result in shear forces that induce vWF interaction with platelets in the circulation and, in turn, trigger platelet clearance, vWF degradation, and the impairment of primary hemostasis.


Key Words: von Willebrand factor • platelets • stenosis • valves




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Klovaite, F. Gustafsson, S. A. Mortensen, K. Sander, and L. B. Nielsen
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2162 - 2167.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. Malehsa, A. L. Meyer, C. Bara, and M. Struber
Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device
Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 1091 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
M. W. Massyn and S. A. Khan
Heyde syndrome: a common diagnosis in older patients with severe aortic stenosis
Age Ageing, May 1, 2009; 38(3): 267 - 270.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. K. Mishra, J. Kovac, J. de Caestecker, G. Fancourt, E. Logtens, and T. Spyt
Intestinal angiodysplasia and aortic valve stenosis: let's not close the book on this association
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 628 - 634.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, P. Biglioli, E. Tremoli, and F. Alamanni
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 493 - 504.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Le Tourneau, S. Susen, C. Caron, A. Millaire, S. Marechaux, A.-S. Polge, A. Vincentelli, F. Mouquet, P.-V. Ennezat, N. Lamblin, et al.
Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction
Circulation, October 7, 2008; 118(15): 1550 - 1557.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Yoshida, S. Tobe, and M. Kawata
Acquired von Willebrand Disease Type IIA in Patients with Aortic Valve Stenosis
Ann. Thorac. Surg., March 1, 2006; 81(3): 1114 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Yoshida, S. Tobe, M. Kawata, and M. Yamaguchi
Acquired and Reversible von Willebrand Disease With High Shear Stress Aortic Valve Stenosis
Ann. Thorac. Surg., February 1, 2006; 81(2): 490 - 494.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Tao, Y. Peng, L. Nolasco, S. Cal, C. Lopez-Otin, R. Li, J. L. Moake, J. A. Lopez, and J.-f. Dong
Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions
Blood, December 15, 2005; 106(13): 4139 - 4145.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. M. Mannucci
Treatment of von Willebrand's Disease
N. Engl. J. Med., August 12, 2004; 351(7): 683 - 694.
[Full Text] [PDF]


Home page
NEJMHome page
A. Vincentelli, S. Susen, T. Le Tourneau, I. Six, O. Fabre, F. Juthier, A. Bauters, C. Decoene, J. Goudemand, A. Prat, et al.
Acquired von Willebrand Syndrome in Aortic Stenosis
N. Engl. J. Med., July 24, 2003; 349(4): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
L. H. Caramuru, R. D. P. S. Soares, N. Y. Maeda, and A. A. Lopes
Hypoxia and Altered Platelet Behavior Influence von Willebrand Factor Multimeric Composition in Secondary Pulmonary Hypertension
Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 251 - 258.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
P. Gresele, G. Guglielmini, M. De Angelis, S. Ciferri, M. Ciofetta, E. Falcinelli, C. Lalli, G. Ciabattoni, G. Davi, and G. B. Bolli
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1013 - 1020.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. E. Warkentin, J. C. Moore, and D. G. Morgan
Gastrointestinal Angiodysplasia and Aortic Stenosis
N. Engl. J. Med., September 12, 2002; 347(11): 858 - 859.
[Full Text] [PDF]


Home page
HeartHome page
R Rauch, U Budde, A Koch, M Girisch, and M Hofbeck
Acquired von Willebrand syndrome in children with patent ductus arteriosus
Heart, July 1, 2002; 88(1): 87 - 88.
[Full Text] [PDF]